Literature DB >> 1284058

Close correlation between hepatitis C virus serology and polymerase chain reaction in chronically infected patients.

D Reuter1, S Polywka, L Iske, H H Feucht, R Laufs.   

Abstract

To determine whether the persistent presence of antibodies to recombinant antigens of the hepatitis C virus (HCV) corresponds to the presence of hepatitis C virus RNA in the same serum, 85 anti-HCV positive patients were studied by the polymerase chain reaction (PCR). The focus of the research was on patients with chronic hepatitis. Eighty- three patients were found to be positive by PCR; only two were negative. In addition, liver biopsies taken from seven patients positive for anti-HCV were shown to contain HCV-specific RNA. Sera collected from three patients suspected to have NANB hepatitis on the basis of clinical symptoms were negative both for HCV antibodies and HCV RNA. The correlation between HCV antibody positivity and detection of HCV RNA was 97.6%.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1284058     DOI: 10.1007/bf01710675

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  16 in total

1.  Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome.

Authors:  Q L Choo; G Kuo; A J Weiner; L R Overby; D W Bradley; M Houghton
Journal:  Science       Date:  1989-04-21       Impact factor: 47.728

2.  Seroconversion for hepatitis C virus antibody in bone marrow recipients treated with immune globulin.

Authors:  H A Horst; N Schmitz; C Glinike; H Löffler; R Laufs
Journal:  N Engl J Med       Date:  1991-07-11       Impact factor: 91.245

3.  False-positive result of hepatitis C enzyme-linked immunosorbent assay in children with autoimmune hepatitis.

Authors:  F Alvarez; P Martres; G Maggiore; O Bernard; E Dussaix
Journal:  J Pediatr       Date:  1991-07       Impact factor: 4.406

4.  Interference of heparin with the polymerase chain reaction.

Authors:  E Beutler; T Gelbart; W Kuhl
Journal:  Biotechniques       Date:  1990-08       Impact factor: 1.993

5.  Treatment of chronic hepatitis C with recombinant interferon alfa. A multicenter randomized, controlled trial.

Authors:  G L Davis; L A Balart; E R Schiff; K Lindsay; H C Bodenheimer; R P Perrillo; W Carey; I M Jacobson; J Payne; J L Dienstag
Journal:  N Engl J Med       Date:  1989-11-30       Impact factor: 91.245

6.  Risk factors for acute non-A, non-B hepatitis in the United States and association with hepatitis C virus infection.

Authors:  M J Alter; S C Hadler; F N Judson; A Mares; W J Alexander; P Y Hu; J K Miller; L A Moyer; H A Fields; D W Bradley
Journal:  JAMA       Date:  1990-11-07       Impact factor: 56.272

7.  The 5'-terminal sequence of the hepatitis C virus genome.

Authors:  H Okamoto; S Okada; Y Sugiyama; S Yotsumoto; T Tanaka; H Yoshizawa; F Tsuda; Y Miyakawa; M Mayumi
Journal:  Jpn J Exp Med       Date:  1990-06

Review 8.  Non-A, non-B hepatitis: evolving epidemiologic and clinical perspective.

Authors:  J L Dienstag; H J Alter
Journal:  Semin Liver Dis       Date:  1986-02       Impact factor: 6.115

9.  Characterization of the terminal regions of hepatitis C viral RNA: identification of conserved sequences in the 5' untranslated region and poly(A) tails at the 3' end.

Authors:  J H Han; V Shyamala; K H Richman; M J Brauer; B Irvine; M S Urdea; P Tekamp-Olson; G Kuo; Q L Choo; M Houghton
Journal:  Proc Natl Acad Sci U S A       Date:  1991-03-01       Impact factor: 11.205

10.  An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis.

Authors:  G Kuo; Q L Choo; H J Alter; G L Gitnick; A G Redeker; R H Purcell; T Miyamura; J L Dienstag; M J Alter; C E Stevens
Journal:  Science       Date:  1989-04-21       Impact factor: 47.728

View more
  5 in total

1.  Hepatitis C virus infection in pregnancy and the risk of mother-to-child transmission.

Authors:  S Polywka; H Feucht; B Zöllner; R Laufs
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1997-02       Impact factor: 3.267

Review 2.  Human Immunoglobulins for intravenous use and hepatitis C viral transmission.

Authors:  H B Slade
Journal:  Clin Diagn Lab Immunol       Date:  1994-11

3.  Distribution of genotypes and response to alpha-interferon in patients with hepatitis C virus infection in Germany.

Authors:  H H Feucht; B Zöllner; M Schröter; A Hoyer; M Sterneck; S Polywka
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1996-02       Impact factor: 3.267

4.  Study on reliability of commercially available hepatitis C virus antibody tests.

Authors:  H H Feucht; B Zöllner; S Polywka; R Laufs
Journal:  J Clin Microbiol       Date:  1995-03       Impact factor: 5.948

5.  Relevance of reactivity in commercially available hepatitis C virus antibody assays.

Authors:  S Polywka; M Schröter; H H Feucht; B Zöllner; R Laufs
Journal:  J Clin Microbiol       Date:  2001-04       Impact factor: 5.948

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.